{"filing":{"accession_number":"0001437749-26-023638","cik":"0001617867","ticker":"AMIX","company_name":"Autonomix Medical, Inc.","form":"8-K","filing_date":"2026-07-15","report_date":null,"primary_document":"amix20260714c_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1617867/000143774926023638/amix20260714c_8k.htm"},"events":[{"id":18204,"run_id":16356,"accession_number":"0001437749-26-023638","anchor_item_number":"1.01","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.92,"summary":"Autonomix Medical entered into a warrant inducement agreement whereby it issued unregistered Series D-1 and Series D-2 warrants (collectively to purchase 857,462 shares) in exchange for the investor's exercise of existing warrants, generating approximately $2.6 million in gross proceeds. The new warrants were issued pursuant to Section 4(a)(2) exemption as a private placement of unregistered equity securities, diluting existing shareholders.","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-15","form":"8-K","submitted_at":null,"items":[{"id":16942,"accession_number":"0001437749-26-023638","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Autonomix Medical entered into a warrant inducement agreement whereby it issued unregistered Series D-1 and Series D-2 warrants (collectively to purchase 857,462 shares) in exchange for the investor's exercise of existing warrants. The new warrants are unregistered securities issued pursuant to Section 4(a)(2) exemption, representing a dilutive private placement. While the transaction also involves warrant exercise proceeds (~$2.6M), the core disclosed event is the issuance of new unregistered equity securities (the New Warrants), which is characteristic of a dilutive issuance under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:03:48.589608+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16943,"accession_number":"0001437749-26-023638","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Autonomix Medical issued unregistered Series D-1 and Series D-2 warrants to purchase an aggregate of 857,462 shares of common stock (428,731 shares per series) in a private placement pursuant to Section 4(a)(2) exemption. The Item 3.02 disclosure explicitly states these securities are unregistered and may not be offered or sold absent registration or exemption. This is a classic dilutive equity issuance to raise capital ($2.6 million in gross proceeds from the warrant exercise), typical of small-cap companies accessing private placement markets.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:03:48.589608+00:00","company_name":"","ticker":null,"filing_date":""},{"id":16944,"accession_number":"0001437749-26-023638","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Autonomix Medical announced a warrant inducement agreement involving the exercise of existing warrants for $2.6 million in gross proceeds and the issuance of new unregistered Series D-1 and D-2 warrants (857,462 shares total at $5.75 exercise price) as consideration. This is a dilutive capital-raising transaction involving private placement of unregistered securities, characteristic of a dilutive issuance. While the primary cash comes from exercising existing warrants, the material event is the issuance of new unregistered warrants to induce that exercise—a classic warrant inducement structure that dilutes existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:03:48.589608+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":16942,"accession_number":"0001437749-26-023638","item_number":"1.01","item_title":"Entry into a Material Definitive Agreement.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Autonomix Medical entered into a warrant inducement agreement whereby it issued unregistered Series D-1 and Series D-2 warrants (collectively to purchase 857,462 shares) in exchange for the investor's exercise of existing warrants. The new warrants are unregistered securities issued pursuant to Section 4(a)(2) exemption, representing a dilutive private placement. While the transaction also involves warrant exercise proceeds (~$2.6M), the core disclosed event is the issuance of new unregistered equity securities (the New Warrants), which is characteristic of a dilutive issuance under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:03:48.589608+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-15"},{"id":16943,"accession_number":"0001437749-26-023638","item_number":"3.02","item_title":"Unregistered Sales of Equity Securities.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"Autonomix Medical issued unregistered Series D-1 and Series D-2 warrants to purchase an aggregate of 857,462 shares of common stock (428,731 shares per series) in a private placement pursuant to Section 4(a)(2) exemption. The Item 3.02 disclosure explicitly states these securities are unregistered and may not be offered or sold absent registration or exemption. This is a classic dilutive equity issuance to raise capital ($2.6 million in gross proceeds from the warrant exercise), typical of small-cap companies accessing private placement markets.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:03:48.589608+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-15"},{"id":16944,"accession_number":"0001437749-26-023638","item_number":"8.01","item_title":"Other Events.","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Autonomix Medical announced a warrant inducement agreement involving the exercise of existing warrants for $2.6 million in gross proceeds and the issuance of new unregistered Series D-1 and D-2 warrants (857,462 shares total at $5.75 exercise price) as consideration. This is a dilutive capital-raising transaction involving private placement of unregistered securities, characteristic of a dilutive issuance. While the primary cash comes from exercising existing warrants, the material event is the issuance of new unregistered warrants to induce that exercise—a classic warrant inducement structure that dilutes existing shareholders.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-15T21:03:48.589608+00:00","company_name":"Autonomix Medical, Inc.","ticker":"AMIX","filing_date":"2026-07-15"}]}